Home / Stocks / KLRA

KLRA insider trading

Kailera Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$326.8M
Buys · last 90 days
0 · $0
Most recent buy
2026-04-22

Cluster buy detected

3 insiders bought KLRA within a short window (2026-04-20), $326.8M in total — cluster score 45/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-04-22RTW INVESTMENTS, LPcluster
10% owner
Bought500,000$16.00$8.0M
2026-04-20BAIN CAPITAL INVESTORS LLCcluster
10% owner
Bought8,398,438$16.00$134.4M
2026-04-20Koppel Adamcluster
Director · 10% owner
Bought1,562,500$16.00$25.0M
2026-04-20BCLS Fund IV Investments GP, LLCcluster
10% owner
Bought1,562,500$16.00$25.0M
2026-04-20Kaplan Andrew T.cluster
Director · 10% owner
Bought8,398,438$16.00$134.4M

Most active insider buyers

InsiderRoleBuysTotal bought
BAIN CAPITAL INVESTORS LLC10% owner1$134.4M
Kaplan Andrew T.Director · 10% owner1$134.4M
Koppel AdamDirector · 10% owner1$25.0M
BCLS Fund IV Investments GP, LLC10% owner1$25.0M
RTW INVESTMENTS, LP10% owner1$8.0M

See KLRA on the chart

Every insider buy and sell for KLRA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.